Ovarian cancer G protein coupled receptor 1 suppresses cell migration of MCF7 breast cancer cells via a Gα12/13-Rho-Rac1 pathway
Tóm tắt
Ovarian cancer G protein coupled receptor 1 (OGR1) mediates inhibitory effects on cell migration in human prostate and ovarian cancer cells. However, the mechanisms and signaling pathways that mediate these inhibitory effects are essentially unknown. MCF7 cell line was chosen as a model system to study the mechanisms by which OGR1 regulates cell migration, since it expresses very low levels of endogenous OGR1. Cell migratory activities were assessed using both wound healing and transwell migration assays. The signaling pathways involved were studied using pharmacological inhibitors and genetic forms of the relevant genes, as well as small G protein pull-down activity assays. The expression levels of various signaling molecules were analyzed by Western blot and quantitative PCR analysis. Over-expression of OGR1 in MCF7 cells substantially enhanced activation of Rho and inhibition of Rac1, resulting in inhibition of cell migration. In addition, expression of the Gα12/13 specific regulator of G protein signaling (RGS) domain of p115RhoGEF, but not treatment with pertussis toxin (PTX, a Gαi specific inhibitor), could abrogate OGR1-dependent Rho activation, Rac1 inactivation, and inhibition of migration in MCF7 cells. The bioactive lipids tested had no effect on OGR1 function in cell migration. Our data suggest, for the first time, that OGR1 inhibits cell migration through a Gα12/13 -Rho-Rac1 signaling pathway in MCF7 cells. This pathway was not significantly affected by bioactive lipids and all the assays were conducted at constant pH, suggesting a constitutive activity of OGR1. This is the first clear delineation of an OGR1-mediated cell signaling pathway involved in migration.
Tài liệu tham khảo
Im DS: Two ligands for a GPCR, proton vs lysolipid. Acta Pharmacol Sin 2005,26(12): 1435–1441.
Tomura H: Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: A novel type of multi-functional receptors. Cell Signal 2005,17(12): 1466–1476.
Ludwig MG: Proton-sensing G-protein-coupled receptors. Nature 2003,425(6953): 93–98.
Murakami N: G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 2004,279(41): 42484–42491.
Wang JQ: TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 2004,279(44): 45626–45633.
Li H: Abnormalities in Osteoclastogenesis and Decreased Tumorigenesis in Mice Deficient for Ovarian Cancer G Protein-Coupled Receptor 1. PLoS One 2009,4(5): e5705.
Yang LV: Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor. Mol Cell Biol 2007,27(4): 1334–1347.
Radu CG: Normal immune development and glucocorticoid-induced thymocyte apoptosis in mice deficient for the T-Cell death-associated gene 8 receptor. Mol Cell Biol 2006,26(2): 668–677.
Xu Y, Zhu K: Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 (vol 2, pg 261, 2000). Nat Cell Biol 2000,2(8): E146-E146.
Zhu K: Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. (Retraction of vol 276, pg 41325, 2001). J Biol Chem 2005,280(52): 43280–43280.
Im DS: Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol 2001,153(2): 429–434.
Obinata H: Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J Biol Chem 2005,280(49): 40676–40683.
Singh LS: Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J Natl Cancer Inst 2007,99(17): 1313–1327.
Kim K: GPR4 plays a critical role in endothelial cell function and mediates the effects of s phi ngosylphosphorylcholine. FASEB J 2005,19(2): 819.
Hasskarl J, Kaufmann M, Schmid HA: Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors. Future Oncol 2011,7(7): 895–913.
Ren J, Zhang L: Effects of ovarian cancer G protein coupled receptor 1 on the proliferation, migration, and adhesion of human ovarian cancer cells. Chin Med J 2011,124(9): 1327–1332.
Ridley AJ: Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 2006,16(10): 522–529.
Kraynov VS: Localized Rac activation dynamics visualized in living cells. Science 2000,290(5490): 333–337.
Raftopoulou M, Hall A: Cell migration: Rho GTPases lead the way. Dev Biol 2004,265(1): 23–32.
Rottner K, Hall A, Small JV: Interplay between Rac and Rho in the control of substrate contact dynamics. Curr Biol 1999,9(12): 640–648.
Beningo KA: Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J Cell Biol 2001,153(4): 881–887.
Munevar S, Wang YL, Dembo M: Distinct roles of frontal and rear cell-substrate adhesions in fibroblast migration. Mol Biol Cell 2001,12(12): 3947–3954.
Arthur WT, Burridge K: RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 2001,12(9): 2711–2720.
Wang HR: Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003,302(5651): 1775–1779.
Worthylake RA, Burridge K: RhoA and ROCK promote migration by limiting membrane protrusions. J Biol Chem 2003,278(15): 13578–13584.
Kozma R: The Ras-related protein cdc42hs and bradykinin promote formation of peripheral actin microspikes and filopodia in swiss 3t3 fibroblasts. Mol Cell Biol 1995,15(4): 1942–1952.
Nobes CD, Hall A: Rho, Rac, and Cdc42 Gtpases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia. Filopodia Cell 1995,81(1): 53–62.
Seifert A: TCDD induces cell migration via NFATc1/ATX-signaling in MCF-7 cells. Toxicol Lett 2009,184(1): 26–32.
Sarkar S: Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett 2005,579(24): 5313–5317.
Wyder L: Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor. Angiogenesis 2011,14(4): 533–544.
Sahai E, Marshall CJ: RHO-GTPases and cancer. Nat Rev Cancer 2002,2(2): 133.
Sugimoto N: Inhibitory and stimulatory regulation of Rac and cell motility by the G(12/13)-Rho and G(i) pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 2003,23(5): 1534–1545.
Arikawa K: Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P(2) G protein-coupled receptor - Requirement of inhibition of cellular Rac activity. J Biol Chem 2003,278(35): 32841–32851.
Malchnkhuu E: S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem Biophys Res Commun 2008,366(4): 963–968.
Lepley D: The G protein-coupled receptor S1P(2) regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res 2005,65(9): 3788–3795.
Sanchez T: PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci USA 2005,102(12): 4312–4317.
Takashima S: G(12/13) and G(q) mediate S1P(2)-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. Cardiovasc Res 2008,79(4): 689–697.
Ortiz-Lopez L: ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 2009,46(1): 15–21.
Tabu K: Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA. Mol Cancer Res 2007,5(10): 1099–1109.
Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth-factors. Cell 1992,70(3): 389–399.
Mogi C: Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. J Pharmacol Sci 2005,99(2): 160–167.